Present status of cholera vaccines.

نویسندگان

  • M M Levine
  • R E Black
  • M L Clements
  • J B Kaper
چکیده

crease in enterotoxin production. Based on their findings, toxin-enriched culture filtrates for separation studies have been produced by the Centre for Applied Microbiology and Research, Porton Down, in collaboration with this laboratory, using a 20 litre batch fermentation technique with controlled pH 7.5, aeration of 10 litres/min, agitation at 500rev./min and incubation at 36°C for 5-6h. Cells were removed by continuous centrifugation and the enterotoxin extracted from concentrated culture filtrates using narrowrange preparative isoelectric focusing in dextran gel (Turnbull et a[., 19796). The diarrhoeal enterotoxin is a thermolabile antigenic protein produced to some degree by most strains of B. cereus. As a metabolite it is distinct from phospholipase C and the two haemolysins of B. cereus, and constitutes one of the two lethal factors produced by this organism (the other being the thiol-activated haemolysin, cereolysin). The instability of the enterotoxin, its sensitivity to proteolytic enzymes, the partial loss of toxigenicity in strains on repeated sub-culture and the problems encountered in separating it from other metabolites of B. cereus have all contributed to the slow progress in purification of the product. Although complete purification and characterization are still awaited there is now good evidence that this enterotoxin is responsible for the diarrhoeal syndrome of illness, and that the dermonecrotic and intestinonecrotic properties are relevant in the pathogenesis of the various non-gastrointestinal B. cereus infections (Turnbull & Kramer, 1983). The emetic toxin produced by B. cereus has only been partially purified (Melling & Capel, 1978; Melling et al., 1978). Optimal production occurs in a rice culture slurry incubated at 25-30°C during the stationary growth phase of the organism (Fig. 2) and synthesis may be associated with sporulation. This toxin is a non-antigenic polypeptide of low relative molecular mass possessing remarkable properties in its stability to heat, pH extremes and enzymes. Strains of B. cereus that synthesize this toxin are not exceptional with respect to their ability to produce other metabolites including the diarrhoeal toxin, but until a simpler model than monkey feeding is available it is not possible to predict the proportion of strains that might be able to elaborate the toxin. Epidemiological evidence, however, that 75% of strains incriminated in the emetic syndrome outbreaks are serotype 1 suggest that only certain strains may be able to produce this toxin; the spores of serotype 1 strains also exhibit a markedly higher resistance to heat than spores of other serotypes. A detailed review of the principal toxic metabolites produced by B. cereus has been presented by Turnbull (1981).

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Current status of cholera and rise of novel mucosal vaccine.

Three serious cholera epidemics have threatened the world during the last 10 years. As a countermeasure against such cholera epidemics, three vaccines, CVD 103-HgR, WC/rBS, and Vietnamese WC, showed good performance. CVD 103-HgR is a recombinant attenuated live vaccine for travelers, and its highly safety and protective efficacy have been demonstrated in volunteers in advanced countries. WC/rBS...

متن کامل

Status of New Cholera Vaccines

The prospect of developing an effective cholera vaccine has improved in recent years, with increased understanding of the mucosal immune system that protects against enteric infections and the discovery that volunteers recovering from cholera were substantially protected against reinfection for several years. The ideal vaccine would be cheap, safe, easy to administer, and effective after a sing...

متن کامل

Studies on the Potency of Prophylactic Vaccines. 1. Cholera Vaccine

f B. M. PAUL 'o,n the Cholera Bacteriological Enquiry, Indian esca,ch Fund Association, School of Tropical Medicine, Calcutta) Cholera vaccine is extensively used foi Prophylaxis, particularly during epidemics of cholera and in endemic areas of the disease. 1 here are three main sources of cholera vaccine, vaccines prepared by certain recognized oratories, the vaccines prepared by local commerc...

متن کامل

Cholera vaccines.

Cholera causes significant morbidity and mortality worldwide. For travelers, the risk of developing cholera per month of stay in a developing country is approximately 0.001%-0.01%, and cholera may present as traveler's diarrhea. In the United States, only a poorly tolerated, marginally effective, parenterally administered, phenol-inactivated vaccine is available. Outside the United States, 2 ad...

متن کامل

Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.

The authors present a nonparametric method for estimating vaccine efficacy as a smooth function of time from vaccine trials. Use of the method requires a minimum of assumptions. Estimation is based on the smoothed case hazard rate ratio comparing the vaccinated with the unvaccinated. The estimation procedure allows investigators to assess time-varying changes in vaccine-induced protection, such...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Biochemical Society transactions

دوره 12 2  شماره 

صفحات  -

تاریخ انتشار 1984